INTERNATIONAL PATENT: EVOTEC INTERNATIONAL GMBH FILES APPLICATION FOR "MODIFIED OLIGONUCLEOTIDES FOR REDUCING ATXN3 EXPRESSION"

GENEVA, Dec. 15 -- EVOTEC INTERNATIONAL GMBH (Essener Bogen 722419 Hamburg) filed a patent application (PCT/EP2025/065195) for "MODIFIED OLIGONUCLEOTIDES FOR REDUCING ATXN3 EXPRESSION" on Jun 02, 2025. With publication no. WO/2025/252669, the details related to the patent application was published on Dec 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BENIZRI, Sebastien Michel Patrick (c/o Evotec (France) SAS195 route d'Espagne31036 Toulouse), BROOKS, Hilary Jane (c/o Evotec (France) SAS195 route d'Espagne31036 Toulouse), JASCHINSKI, Frank (c/o Secarna Pharmaceuticals GmbH & Co. KGRudolf...